Topics:

Diabetes

Type 2 Diabetes and Medication Adherence: Where is the Disconnect?

Incretin drugs, which offer ease of use, very little hypoglycemia, and no weight gain (or even weight loss) seem to be an ideal therapy. But 80% to 90% of patients don’t stay on them. Why not?

Diabetes

Evidence to date is conflicting on the potential role of antihyperglycemic drugs, old and new, in cardioprotection. Results reported here add to the pool and fuel ongoing study.

The sodium glucose cotransporter-2 inhibitors have many advantages eg, modest A1c reduction and low hypoglycemia risk. But careful patient selection is critical.

A woman with poorly controlled type 2 diabetes presented with widespread “yellow bumps" of sudden onset. What's your diagnosis?

Diabetes and menopause

For nondiabetic women, menopause is an extended biological and physiological purgatory. For those with type 1 or type 2 diabetes, it's worse.

A recent study identifies a sweet spot for use of premixed biphasic insulin 50/50 in routine clinical practice.

Faulty brain satiety centers and impaired gut hormone function are risk factors for weight gain in patients with type 2 diabetes. A recent study suggests one simple antidote: Slow down.

You just diagnosed Mrs Bates as having metabolic syndrome. The unusual fatigue and nocturia she describes make you wonder about another potential diagnosis. How would you proceed?

Pages

Subscribe to Diabetes on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.